Morgan Stanley Assumes Edwards Lifesciences at Overweight, Announces Price Target of $102
Portfolio Pulse from richadhand@benzinga.com
Morgan Stanley analyst Patrick Wood assumes Edwards Lifesciences (NYSE:EW) with an Overweight rating and announces a price target of $102.
May 30, 2023 | 11:33 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley's Patrick Wood assumes Edwards Lifesciences with an Overweight rating and sets a price target of $102.
The Overweight rating and price target of $102 by Morgan Stanley analyst Patrick Wood indicate a positive outlook for Edwards Lifesciences. This news is likely to have a positive impact on the stock price in the short term as it suggests the analyst believes the stock is undervalued and has potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100